Global Nephrotic Syndrome Market Growth Prospects and Strategic Opportunities Through 2029
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Nephrotic Syndrome Market?
The market size for nephrotic syndrome has experienced significant growth in the past few years. A rise from $0.87 billion in 2024 to $0.96 billion in 2025 is expected, with a compound annual growth rate (CAGR) of 10.7%. Factors contributing to this surge during the historical period include the escalating rates of nephrotic syndrome incidence, increasing genetic disorders, the growing prevalence of obesity, the enhanced usage of immunosuppressive medicines, and the emerging influence of genetic elements.
The market size for nephrotic syndrome is projected to witness accelerated growth in the coming years. The market is set to reach $1.43 billion by 2029, with a compound annual growth rate (CAGR) of 10.5%. This growth during the estimated period can be ascribed to factors such as increasing awareness of Nephrotic Syndrome disease, the escalating prevalence of Chronic Kidney Diseases (CKD), the rising incidence of metabolic disorders, the growth of the aged population, and an uptick in the occurrence of autoimmune diseases. Noteworthy trends for the estimated period encompass telehealth and distant monitoring, novel drug delivery systems, progress in treatment methods, advancements in the biotech field, and the incorporation of digital health technologies.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21228&type=smp
What Core Drivers Are Expected To Influence The Nephrotic Syndrome Market?
The rise in kidney-related illnesses is predicted to drive the expansion of the nephrotic syndrome market. The term “kidney diseases” covers all disorders that compromise the kidneys’ role – these essential organs act as filters, eliminating waste and surplus fluids from the bloodstream. Numerous conditions, such as diabetes, hypertension, obesity, aging populations, and lifestyle modifications, including high sodium consumption and insufficient hydration, contribute to the growing prevalence of kidney diseases. Nephrotic syndrome, a significant contributor to kidney diseases, damages the glomeruli, interfering with the kidney’s filtration function and protein retention. For example, the Australian Institute of Health and Welfare, a government agency in Australia, reported in June 2024 that Australia’s chronic kidney disease (CKD) mortality rate surged from 4.2% in 2021 to 6.2% in 2022. Thus, the swelling incidence of kidney ailments propels the nephrotic syndrome market’s expansion.
What Are The Main Segment Classifications In The Nephrotic Syndrome Market?
The nephrotic syndromemarket covered in this report is segmented –
1) By Type: Drugs; Devices
2) By Diagnosis Tests: Urinalysis; Glomerular Filtration Rate (GFR); Blood Test; Kidney Biopsy; Computerized Tomography (CT) Scan
3) By Application: Clinics; Hospitals; Speciality Centres; Other Applications
Subsegments:
1) By Drugs: Steroids; Immunosuppressants; Diuretics; ACE Inhibitors Or ARBs; Other Drugs
2) By Devices: Dialysis Machines; Peritoneal Dialysis Catheters; Hemodialysis Catheters; Kidney Replacement Therapy Devices
How Are Market Trends Influencing Competition In The Nephrotic Syndrome Market?
Major companies in the nephrotic syndrome market are concentrating on creating innovative formulations like loop diuretic injections to enhance fluid management and reduce edema in patients. Loop diuretic injections are medications administered intravenously that inhibit sodium and chloride reabsorption in the loop of Henle, promoting rapid urine output. These injections treat conditions such as acute pulmonary edema, heart failure, and severe hypertension by alleviating fluid overload. For example, in March 2024, Avenacy Inc., a US pharmaceutical company, introduced furosemide for Injection in the U.S., a generic alternative to Lasix, approved by the FDA for managing edema linked to heart failure, liver cirrhosis, and kidney diseases. The product is supplied in 25-unit packs of 100 mg/10 mL doses and is part of Avenacy’s broader plan to expand its injectable drug portfolio, aiming to launch over 20 products in 2024. This medication is indicated for both adult and pediatric patients to treat edema associated with congestive heart failure, liver cirrhosis, and renal diseases including nephrotic syndrome.
Which Companies Are Contributing Significantly To The Nephrotic Syndrome Market Growth?
Major companies operating in the nephrotic syndrome market are Pfizer Inc., F. Hoffmann-La Roche AG, AbbVie Inc., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Amgen Inc., Eli Lilly and Company, Asahi Kasei Corporation, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Vertex Pharmaceuticals, Chugai Pharmaceutical Co. Ltd., Mallinckrodt Company, Evotec SE, Travere Therapeutics Inc., Aurinia Pharmaceuticals Inc., Orbis Biosciences Inc., Alpine Immune Sciences, Kezar Life Sciences, Zenyaku Kogyo Co. Ltd
Access The Complete Report Here:
https://www.thebusinessresearchcompany.com/report/nephrotic-syndrome-global-market-report
Which Region Holds The Greatest Opportunity For Nephrotic Syndrome Market Expansion?
North America was the largest region in the nephrotic syndrome market in 2024. The regions covered in the nephrotic syndrome market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=21228&type=smp
Browse Through More Reports Similar to the Global Nephrotic Syndrome Market 2025, By The Business Research Company
Cough Hypersensitivity Syndrome Global Market Report 2025
Dumping Syndrome Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/dumping-syndrome-global-market-report
Zollinger Ellison Syndrome Treatment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
